Junior research group
Systems Medicine Research in Lymphoma and Leukemias
Lymphomas and leukaemias affect each patient individually. While many patients have a very good prognosis thanks to modern therapies, too many people still suffer from lymphoma as a recurring, sometimes fatal disease. In order to further improve the treatment of lymphoma and leukemia patients, the e:Med junior research group SYMPATHY conducts systems medicine research. This means trying to bring together all the information about the patients, their disease, potential therapies and other factors in order to draw conclusions about the biology of the disease, the best individual therapy and the prognosis in each case.
to the article